Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients

Leukemia, Published online: 11 September 2019; doi:10.1038/s41375-019-0574-xClinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients

Source: Leukemia - September 10, 2019 Category: Hematology Authors: Abhishek A. Mangaonkar David M. Swoboda Giacomo Coltro Terra L. Lasho Paul J. Novotny Prateek Pophali Ryan M. Carr Moritz Binder Christy M. Finke Naseema Gangat Aref Al-Kali Kebede H. Begna Kaaren K. Reichard Rhett P. Ketterling Najla H. Al Ali Pardis Vaf Source Type: research